Literature DB >> 31123957

Turn-on Fluorescence Chemosensor for Zn2+ Ion Using Salicylate Based Azo Derivatives and their Application in Cell-Bioimaging.

Mathappan Mariyappan1, Nelson Malini1, Jayaraman Sivamani1, Gandhi Sivaraman1, Muniyasamy Harikrishnan1, Sepperumal Murugesan1, Ayyanar Siva2.   

Abstract

The synthesis and optical studies of salicylate based azo derivatives (DPSAD and IPSAD) are reported. The receptors act as a versatile fluorogenic chemosensor for Zn2+ causing a selective enhancement of fluorescence over other competing cations. The complex formed between receptors and Zn2+ are identified on the basis of absorption and fluorescence titration and further confirmed by ESI-MS. DFT/TD-DFT calculations support the observed optical changes happens only upon complexation with Zn2+ ion. Moreover, receptors are further applied to intracellular sensing and imaging studies. Graphical Abstract Salicylate based azo derivatives (DPSAD and IPSAD) as fluorogenic chemosensor for the detection of Zn2+ ion.

Entities:  

Keywords:  Azo derivatives; Chemosensor; Intracellular sensing; Salicylate derivative; Zinc ion

Mesh:

Substances:

Year:  2019        PMID: 31123957     DOI: 10.1007/s10895-019-02382-4

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  3 in total

1.  Development of a near infrared novel bioimaging agent via co-oligomerization of Congo red with aniline and o-phenylenediamine: experimental and theoretical studies.

Authors:  Neetika Singh; Prabhat Kumar; Raj Kumar; Elham S Aazam; Ufana Riaz
Journal:  RSC Adv       Date:  2019-11-13       Impact factor: 4.036

2.  Subtle structural variation in azine/imine derivatives controls Zn2+ sensitivity: ESIPT-CHEF combination for nano-molar detection of Zn2+ with DFT support.

Authors:  Somnath Khanra; Sabyasachi Ta; Milan Ghosh; Sudeshna Chatterjee; Debasis Das
Journal:  RSC Adv       Date:  2019-07-08       Impact factor: 4.036

3.  A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells.

Authors:  Yong An; Wei Chang; Wei Wang; Hao Wu; Ke Pu; Anhu Wu; Ze Qin; Yan Tao; Zhongjin Yue; Peng Wang; Zhiping Wang
Journal:  J Adv Res       Date:  2020-04-28       Impact factor: 10.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.